Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: a pragmatic review

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington D.C: American Psychiatric Publishing; 2013.
   Google Scholar
• Kumar A, Trescher W, Byler D. Tourette syndrome and comorbid neuropsychiatric conditions. Curr Dev Disord Rep. 2016;3(4):217–221.
   PubMedGoogle Scholar
• Hirschtritt M, Lee PC, Pauls DL, et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry. 2015;72(4):325–333.
   PubMed Web of Science ®Google Scholar
• Leckman JF, Denys D, Simpson HB, et al. Obssessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety. 2010;27(6):507–527.
   PubMed Web of Science ®Google Scholar
• Purty A, Nestadt G, Samuels JF, et al. Genetics of obsessive-compulsive disorder. Indian J Psychiatry. 2019 Jan;61(Suppl 1):S37–S42.
   PubMedGoogle Scholar
• Yu D, Mathews CA, Scharf JM, et al. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette’s syndrome and OCD. Am J Psychiatry. 2015;172(1):82–93.
   PubMed Web of Science ®Google Scholar
• Kaplan PW. Epilepsy and obsessive-compulsive disorder. Dialogues Clin Neurosci. 2010;12(2):241–248.
   PubMedGoogle Scholar
• Kim SJ, Lee SA, Ryu HU, et al. Factors associated with obsessive-compulsive symptoms in people with epilepsy. Epilepsy Behav. 2020;102:106723.
   PubMed Web of Science ®Google Scholar
• Mier D, Schirmbeck F, Stoessel G, et al. Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine. Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):931–940.
   PubMed Web of Science ®Google Scholar
• Lykouras L, Alevizos B, Michalopoulou P, et al. Obsessive-compulsive symtpoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(3):333–346.
   PubMed Web of Science ®Google Scholar
• Scheltema BAA, Swets M, Machielsen M, et al. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. J Clin Psychiatry. 2012;73(11):1395–1402.
   PubMed Web of Science ®Google Scholar
• Schrimbeck F, Zink M. Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol. 2012;10(1):88–95.
   PubMed Web of Science ®Google Scholar
• Angus-Leppan H, Nash A, Pilling R. Recognising acute lamotrigine induced tourette’s syndrome in adults. Sci J Research Rev. 2019;1(3):1–3. SJRR.MS.ID.000515.
   Google Scholar
• Tran AR, Zito JM, Safer DJ, et al. National trends in pediatric use of anticonvulsants. Psychiatr Serv. 2012;63(11):1095–1101.
   PubMed Web of Science ®Google Scholar
• Lopez-Larson M, Frazier JA. Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders. Harv Rev Psychiatry. 2006;14(6):285–304.
   PubMed Web of Science ®Google Scholar
• Davico C, Canavese C, Vittorini R, et al. Anticonvulsants for psychiatric disorders in children and adolescents: a systematic review of their efficacy. Front Psychiatry. 2018;9:270.
   PubMed Web of Science ®Google Scholar
• Peters J, Vijiaratnam N, Angus-Leppan H. Tics induced by antiepileptic drugs: a pragmatic review. J Neurol. 2021;268(1):321–336.
   PubMed Web of Science ®Google Scholar
• Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021 Mar 29;372(160). DOI:10.1136/bmj.n160.
   Web of Science ®Google Scholar
• Kuloglu M, Caykoylu A, Ekinci O, et al. Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report. J Psychopharmacol. 2009 Nov;23(8):1001–1003. .
   PubMed Web of Science ®Google Scholar
• Szmulewicz AG, Valerio MP, Smith JM. Obsessive–compulsive symptoms in adjunctive therapy with lamotrigine in clozapine-medicated patients. Schizophr Res. 2015;166(1):364–365.
   PubMed Web of Science ®Google Scholar
• Kemp DE, Gilmer WS, Fleck J, et al. An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder. CNS Spectr. 2007;12(2):106–111.
   PubMed Web of Science ®Google Scholar
• de Menezes MAS, Rho JM, Murphy P, et al. Lamotrigine‐induced tic disorder: report of five pediatric cases. Epilepsia. 2000;41(7):862–867.
   PubMed Web of Science ®Google Scholar
• Ozkara C, Ozmen M, Erdogan A, et al. Topiramate related obsessive–compulsive disorder. Eur Psychiatry. 2005;20(1):78–79.
   PubMed Web of Science ®Google Scholar
• Sherer M, Padilla S. A case of obsessiveness induced by levetiracetam in a patient with epilepsy, intellectual disability and pervasive developmental disorder. Ment Health Aspects Dev Disabil. 2008;11(1):22.
   Google Scholar
• Neglia JP, Glaze DG, Zion TE. Tics and vocalizations in children treated with carbamazepine. Pediatrics. 1984;73(6):841–844.
   PubMed Web of Science ®Google Scholar
• Lu D, Lin X, Liu X, et al. Lamotrigine-induced facial tic in a pediatric bipolar disorder patient. J Child Adolesc Psychopharmacol. 2013;23(8):583–584.
   PubMed Web of Science ®Google Scholar
• Alkın T, Onur E, Özerdem A. Co-occurence of blepharospasm, tourettism and obsessive-compulsive symptoms during lamotrigine treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(6):1339–1340.
   PubMed Web of Science ®Google Scholar
• Sharma S, Doobay M. Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder. CNS Spectr. 2019;24(4):390–394.
   PubMed Web of Science ®Google Scholar
• Sharma V, Doobay M. Valproic acid-induced obsessive-compulsive disorder in a patient with bipolar disorder. Bipolar Disord. 2020;22(5):538–540.
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245.
   PubMed Web of Science ®Google Scholar
• Musiek ES, Anders CT, Dahodwala NA, et al. Facial tic associated with lamotrigine in adults. Mov Disord. 2010;25(10):1512–1513.
   PubMed Web of Science ®Google Scholar
• Seemüller F, Dehning S, Grunze H, et al. Tourette’s symptoms provoked by lamotrigine in a bipolar patient. Am J Psychiatry. 2006;163(1):159.
   PubMed Web of Science ®Google Scholar
• Lombroso CT. Lamotrigine-induced tourettism. Neurology. 1999;52(6):1191–1194.
   PubMed Web of Science ®Google Scholar
• Kim DG, Oh SH, Kim OJ. A case of lamotrigine-induced excessive involuntary eye blinking. J Clin Neurol. 2007;3(2):93–95.
   PubMed Web of Science ®Google Scholar
• Çökmüş FP, Aşçıbaşı K, Öztekin S, et al. Relationship of levetiracetam and obsessive-compulsive disorder: a case report. Klinik Psikofarmakoloji Bulteni. 2017;27:325.
   Google Scholar
• Fujikawa M, Kishimoto Y, Kakisaka Y, et al. Obsessive-compulsive behavior induced by levetiracetam. J Child Neurol. 2015;30(7):942–944.
   PubMed Web of Science ®Google Scholar
• Hurtado B, Koepp MJ, Sander JW, et al. The impact of levetiracetam on challenging behavior. Epilepsy Behav. 2006;8(3):588–592.
   PubMed Web of Science ®Google Scholar
• Shukla G, Gupta A, Agarwal P, et al. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine — a retrospective comparison study of North Indian patients with refractory epilepsy. Epilepsy Behav. 2016;64(Pt A):216–218.
   PubMedGoogle Scholar
• Steketee G, Frost R, Bogart K. The Yale-Brown obsessive compulsive scale: interview versus self-report. Behav Res Ther. 1996;34(8):309–322.
   Web of Science ®Google Scholar
• Thuile J, Even C, Guelfi J. Topiramate may induce obsessive‐compulsive disorder. Psychiatry Clin Neurosci. 2006;60(3):394.
   PubMed Web of Science ®Google Scholar
• Weng WC, Huang HL, Wong LC, et al. Increased risks of tic disorders in children with epilepsy: a nation-wide population-based case-control study in Taiwan. Res Dev Disabil. 2016;51-52:173–180.
   PubMed Web of Science ®Google Scholar
• Hirai K, Kimiya S, Tabata K, et al. Selective mutism and obsessive compulsive disorders associated with zonisamide. Seizure. 2002;11(7):468–470.
   PubMed Web of Science ®Google Scholar
• Aguglia U, Zaapia M, Quattrone A. Carbamazepine-induced nonepileptic myoclonus in a child with benign epilepsy. Epilepsia. 1987;28(5):515–518.
   PubMed Web of Science ®Google Scholar
• Holtman M, Korn-Merker E, Boenigk HE. Carbamazepine-induced combined phonic and motor tic in a boy with Down’s syndrome. Epileptic Disord. 2000;2(1):39–40.
   PubMed Web of Science ®Google Scholar
• Magaudda A, Di Rossa G. Carbamazepine-induced non-epileptic myoclonus and tic-like movements. Epilepic Disord. 2012;14(2):172–173.
   PubMed Web of Science ®Google Scholar
• Robertson PL, Garofallo EA, Silverstein FS, et al. Carbamazepine-induced tics. Epilepsia. 1993;34(5):965–968.
   PubMed Web of Science ®Google Scholar
• Kurlan R, Kersun J, Behr J, et al. Carbemazepine-induced tics. Clin Neuropharmacol. 1989;12(4):298–302.
   PubMed Web of Science ®Google Scholar
• Stamouli S, Lykouras L. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases. J Clin Psychopharmacol. 2006;26(4):396–400.
   PubMed Web of Science ®Google Scholar
• Tranulis C, Potvin S, Gourge M, et al. The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr. 2005;10(5):356–361.
   PubMed Web of Science ®Google Scholar
• Fergus TA, Valentiner DP, McGrath PB, et al. Shame- and guilt-proneness: relationships with anxiety disorder symptoms in a clinical sample. J Anxiety Disord. 2010;24(8):811–815.
   PubMed Web of Science ®Google Scholar
• Zaninotto L, Solmi M, Veronese N, et al. A meta-analysis of cognitive performance in melancholic versus non-melancholic unipolar depression. J Affect Disord. 2016;201:15–24.
   PubMed Web of Science ®Google Scholar
• Netto VM, Flores CA, Pallanti S. Pharmacological treatment for comorbid bipolar disorder and obsessive-compulsive disorder in adults. J Psychiatr Pract. 2020 Sep;26(5):383–393.
   PubMed Web of Science ®Google Scholar
• Zhou DD, Zhou XX, Li Y, et al. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: a network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2019;90:277–287.
   PubMed Web of Science ®Google Scholar
• Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA. 2017 Apr;317(13):1358–1367.
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS, Gao Y, Jeannie Roberts R. Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression. Med Hypotheses. 2011 Jun;76(6):769–773.
   PubMed Web of Science ®Google Scholar
• Pollard JR, French J. Antiepileptic drugs in development. Lancet Neurol. 2006;5(12):1064–1067.
   PubMed Web of Science ®Google Scholar
• Wang Z, Maia TV, Marsh R, et al. The neural circuits that generate tics in Tourette’s syndrome. Am J Psychiatry. 2011;168(12):1326–1337.
   PubMed Web of Science ®Google Scholar
• Nakao T, Okada K, Kanba S. Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings. Psychiatry Clin Neurosci. 2014;68(8):587–605.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Fan Q, Bai Y, et al. Brain gamma-aminobutyric acid (GABA) concentration of the prefrontal lobe in unmedicated patients with obsessive-compulsive disorder: a research of magnetic resonance spectroscopy. Shanghai Arch Psychiatry. 2016;28(5):263–270.
   PubMedGoogle Scholar
• Wu K, Hanna GL, Rosenberg DR, et al. The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder. Pharmacol Biochem Behav. 2012;100(4):726–735.
   PubMed Web of Science ®Google Scholar
• Miziak B, Chrościńska-Krawczyk M, Czuczwar SJ. Neurosteroids and seizure activity. Front Endocrinol (Lausanne). 2020 Published 2020 Sep 30;11:541802.
   PubMed Web of Science ®Google Scholar
• Erbay LG, Kartalci S. Neurosteroid levels in patients with obsessive-compulsive disorder. Psychiatry Investig. 2015;12(4):538–544.
   PubMed Web of Science ®Google Scholar
• Costa AM, Lucchi C, Malkoç A, et al. Relationship between delta rhythm, seizure occurrence and allopregnanolone hippocampal levels in epileptic rats exposed to the rebound effect. Pharmaceuticals (Basel). 2021;14(2):127.
   PubMedGoogle Scholar
• Albert U, Marazziti D, Di Salvo G, et al. A systematic review of evidence-based treatment strategies for obsessive- compulsive disorder resistant to first-line pharmacotherapy. Curr Med Chem. 2018;25(41):5647–5661.
   PubMed Web of Science ®Google Scholar
• Reid JE, Laws KR, Drummond L, et al. Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of randomised controlled trials. Compr Psychiatry. 2021;106:152223.
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Glick I, Koran LM. Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms. J Psychopharmacol. 2010;24(6):861–866.
   PubMed Web of Science ®Google Scholar